Results 21 to 30 of about 10,212 (176)

Genetic Polymorphisms of Superoxide Dismutase Locus of Pneumocystis jirovecii in Spanish Population

Frontiers in Public Health, 2019
Objective:Pneumocystis pneumonia remains a major opportunistic infection in immunocompromised patients worldwide. Colonization with Pneumocystis jirovecii has recently gained attention as an important issue for understanding the complete cycle of human ...
Rubén Morilla, Rubén Morilla, Rubén Morilla, Amaia González-Magaña, Amaia González-Magaña, Vicente Friaza, Yaxsier de Armas, Francisco J. Medrano, Francisco J. Medrano, Enrique J. Calderón, Enrique J. Calderón, Carmen de la Horra, Carmen de la Horra   +12 more
doaj   +1 more source

Pneumocystis jiroveciipneumonia in developing countries [PDF]

Parasite, 2011
Pneumocystis pneumonia (PcP) is a serious fungal infection among immunocompromised patients. In developed countries, the epidemiology and clinical spectrum of PcP have been clearly defined and well documented. However, in most developing countries, relatively little is known about the prevalence of pneumocystosis.
Yaxsier de Armas Rodríguez, Gustavo Wissmann, André Luis Aquino Müller, Marco Aurélio Pederiva, Maria Carlota Borba Brum, R.L. Brackmann, Virginia Capó de Paz, E. Calderón   +7 more
openaire   +3 more sources

Purine antimetabolites associated Pneumocystis jirovecii pneumonia

Pharmacoepidemiology and Drug Safety, 2023
AbstractPurposeTo detect the possible safety signal of purine antimetabolites associated with Pneumocystis jirovecii pneumonia through disproportionality analysis in the FDA Adverse Event Reporting System (FAERS) Database.MethodsA case/non‐case retrospective disproportionality analysis was performed in the publicly available FAERS database using ...
Lipin Lukose, Pawar Mansi Shantaram, Alan Raj, Gouri Nair, Aina M. Shaju, Viswam K. Subeesh   +5 more
openaire   +2 more sources

Coexistência de infeções oportunistas pulmonares num doente com infeção por vírus da imunodeficiência humana e uma forma persistente de pneumonia por Pneumocystis jirovecii: caso clínico

Revista Portuguesa de Pneumologia, 2013
Resumo: Como é sabido, nos doentes com infeção por vírus da imunodeficiência humana (VIH) existe um alto risco de ocorrência de infeções oportunistas (IO), tais como as infeções por Pneumocystis jirovecii, um agente patogénico com distribuição mundial ...
D. Ponces Bento, F. Esteves, O. Matos, A.C. Miranda, F. Ventura, C. Araújo, K. Mansinho   +6 more
doaj   +1 more source

Pneumocystis jirovecii colonization in chronic pulmonary disease

Parasite, 2011
Pneumocystis jirovecii causes pneumonia in immunosuppressed individuals. However, it has been reported the detection of low levels of Pneumocystis DNA in patients without signs and symptoms of pneumonia, which likely represents colonization.
Gutiérrez S., Respaldiza N., Campano E., Martínez-Risquez M.T., Calderón E.J., De La Horra C.   +5 more
doaj   +1 more source

Virtual Screening of Phytochemicals to Novel Target (HAT) Rtt109 in Pneumocystis Jirovecii using Bioinformatics Tools [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: Pneumocystis jirovecii is a fungus that causes Pneumocystis pneumonia in HIV and other immunosuppressed patients. Treatment of Pneumocystis pneumonia with the currently available antifungals is challenging and associated with ...
Ramya Sugumar, Abhinand Ponneri Adithavarman, Anusha Dakshinamoorthi, Darling Chellathai David, Padmavathi Kannan Ragunath   +4 more
doaj   +1 more source

Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia

Journal of Infection in Developing Countries, 2010
Introduction: Pneumocystis jirovecii dihydropteroate synthase (DHPS) gene mutations' (55th and 57th codon) association with prior sulfa prophylaxis failure has been reported from both developed and developing countries.
Anuj Kumar Tyagi, Bijay Ranjan Mirdha, Kalpana Luthra, Randeep Guleria, Anant Mohan, Urvashi Balbir Singh, Jyotish Chandra Samantaray, Lalit Dar, Venkateswaran K Iyer, Rama Chaudhry   +9 more
doaj   +1 more source

Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous–venous extracorporeal membrane oxygenation (VV‐ECMO): A case report

British Journal of Clinical Pharmacology, EarlyView.
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart, Emiel Leegwater, Thomas H. Ottens, Emile F. Schippers, Erik B. Wilms, David M. Burger, Cees van Nieuwkoop, Liesbeth B. E. Bosma   +7 more
wiley   +1 more source

Pneumocystis pneumonia in a treatment-naive rheumatoid arthritis patient

IDCases, 2019
A HIV-negative, newly diagnosed patient with rheumatoid arthritis (RA) was found to have pneumocystis jiroveci pneumonia. The infection was treated with three weeks of atovaquone and corticosteroids.
Anuoluwapo Shobayo, Chiemeziem Nwanyanwu, Edward Chapnick   +2 more
doaj   +1 more source

Fast and Accurate Pneumocystis Pneumonia Diagnosis in Human Samples Using a Label-Free Plasmonic Biosensor

Nanomaterials, 2020
Pneumocystis jirovecii is a fungus responsible for human Pneumocystis pneumonia, one of the most severe infections encountered in immunodepressed individuals.
Olalla Calvo-Lozano, Anna Aviñó, Vicente Friaza, Alfonso Medina-Escuela, César S. Huertas, Enrique J. Calderón, Ramón Eritja, Laura M. Lechuga   +7 more
doaj   +1 more source